Circulating Histocompatibility Antigen (HLA) Gene Products May Help Differentiate Benign from Malignant Indeterminate Pulmonary Lesions.

Smriti Kanangat,Christopher W Seder,Melissa R Pergande,Gabriela C Lobato,Cristina L Fhied, Maryam F Raouf,Michael J Liptay,Jeffrey A Borgia

Human Immunology（2018）

引用 2|浏览20

暂无评分

摘要

Soluble HLA molecules may have diagnostic value for early-stage NSCLC. Validation studies are currently underway using sera from a lung cancer screening cohort.

查看译文

关键词

NSCLC,HLA,LDCT,MHC,ATCC,RPMI,SDS-PAGE,LOH

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要